Pathogenicity of IgG subclass autoantibodies to type VII collagen: Induction of dermal-epidermal separation

Journal of Autoimmunity

Volumn 34, Issue 4, 2010, Pages 435-444

  Recke, Andreas ^a   Sitaru, Cassian ^a   Vidarsson, Gestur ^b   Evensen, Mirja ^a   Chiriac, Mircea T ^a   Ludwig, Ralf J ^a   Zillikens, Detlef ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Autoantibody; Bullous dermatoses; Complement; Ex vivo model; Leukocytes; Type VII collagen

Indexed keywords

COLLAGEN TYPE 7; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G3 ANTIBODY; RECOMBINANT ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN BINDING; ARTICLE; AUTOIMMUNITY; BINDING AFFINITY; COMPLEMENT ACTIVATION; CONTROLLED STUDY; EPIDERMOLYSIS; EX VIVO STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOGENESIS; MOUSE; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENICITY; PRIORITY JOURNAL;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNITY; COLLAGEN TYPE VII; DERMIS; EPIDERMIS; HUMANS; IMMUNOGLOBULIN FRAGMENTS; IMMUNOGLOBULIN G; MICE; PROTEIN ENGINEERING; RECOMBINANT PROTEINS;

EID: 77952243471     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2009.11.003     Document Type: Article

References (60)

1. Woodley D.T., Briggaman R.A., O'Keefe E.J., Inman A.O., Queen L.L., Gammon W.R. Identification of the skin basement-membrane autoantigen in epidermolysis bullosa acquisita. N Engl J Med 1984, 310(16):1007-1013.
2. Woodley D.T., Burgeson R.E., Lunstrum G., Bruckner-Tuderman L., Reese M.J., Briggaman R.A. Epidermolysis bullosa acquisita antigen is the globular carboxyl terminus of type VII procollagen. J Clin Invest 1988, 81(3):683-687.
3. Gammon W.R., Murrell D.F., Jenison M.W., Padilla K.M., Prisayanh P.S., Jones D.A., et al. Autoantibodies to type VII collagen recognize epitopes in a fibronectin-like region of the noncollagenous (NC1) domain. J Invest Dermatol 1993, 100(5):618-622.
4. Oostingh G.J., Sitaru C., Zillikens D., Kromminga A., Lührs H. Subclass distribution of type VII collagen-specific autoantibodies in patients with inflammatory bowel disease. J Dermatol Sci 2005, 37(3):182-184. URL. http://dx.doi.org/10.1016/j.jdermsci.2004.11.010, 10.1016/j.jdermsci.2004.11.010.
5. Chen M., O'Toole E.A., Sanghavi J., Mahmud N., Kelleher D., Weir D., et al. The epidermolysis bullosa acquisita antigen (type VII collagen) is present in human colon and patients with crohn's disease have autoantibodies to type VII collagen. J Invest Dermatol 2002, 118(6):1059-1064. URL. http://dx.doi.org/10.1046/j.1523-1747.2002.01772.x, 10.1046/j.1523-1747.2002.01772.x.
6. Remington J., Chen M., Burnett J., Woodley D.T. Autoimmunity to type VII collagen: epidermolysis bullosa acquisita. Curr Dir Autoimmun 2008, 10:195-205. URL. http://dx.doi.org/10.1159/000131455, 10.1159/000131455.
7. Lapiere J.C., Woodley D.T., Parente M.G., Iwasaki T., Wynn K.C., Christiano A.M., et al. Epitope mapping of type VII collagen. Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa. J Clin Invest 1993, 92(4):1831-1839.
8. Tanaka T., Furukawa F., Imamura S. Epitope mapping for epidermolysis bullosa acquisita autoantibody by molecularly cloned cDNA for type VII collagen. J Invest Dermatol 1994, 102(5):706-709.
9. Chen M., Doostan A., Bandyopadhyay P., Remington J., Wang X., Hou Y., et al. The cartilage matrix protein subdomain of type VII collagen is pathogenic for epidermolysis bullosa acquisita. Am J Pathol 2007, 170(6):2009-2018.
10. Sitaru C., Kromminga A., Hashimoto T., Bröcker E.B., Zillikens D. Autoantibodies to type VII collagen mediate Fcgamma-dependent neutrophil activation and induce dermal-epidermal separation in cryosections of human skin. Am J Pathol 2002, 161(1):301-311.
11. Shimanovich I., Mihai S., Oostingh G.J., Ilenchuk T.T., Bröcker E.-B., Opdenakker G., et al. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid. J Pathol 2004, 204(5):519-527. URL. http://dx.doi.org/10.1002/path.1674, 10.1002/path.1674.
12. Sitaru C., Mihai S., Otto C., Chiriac M.T., Hausser I., Dotterweich B., et al. Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen. J Clin Invest 2005, 115(4):870-878. URL. http://dx.doi.org/10.1172/JCI200521386, 10.1172/JCI200521386.
13. Woodley D.T., Chang C., Saadat P., Ram R., Liu Z., Chen M. Evidence that anti-type VII collagen antibodies are pathogenic and responsible for the clinical, histological, and immunological features of epidermolysis bullosa acquisita. J Invest Dermatol 2005, 124(5):958-964. URL. http://dx.doi.org/10.1111/j.0022-202X.2005.23702.x, 10.1111/j.0022-202X.2005.23702.x.
14. Woodley D.T., Ram R., Doostan A., Bandyopadhyay P., Huang Y., Remington J., et al. Induction of epidermolysis bullosa acquisita in mice by passive transfer of autoantibodies from patients. J Invest Dermatol 2006, 126(6):1323-1330. URL. http://dx.doi.org/10.1038/sj.jid.5700254, 10.1038/sj.jid.5700254.
15. Herrero-González J.E., Mascaró J.M., Herrero C., Dilling A., Zillikens D., Sitaru C. Autoantibodies from patients with BSLE inducing recruitment of leukocytes to the dermoepidermal junction and subepidermal splits in cryosections of human skin. Arch Dermatol 2006, 142(11):1513-1516. URL. http://dx.doi.org/10.1001/archderm.142.11.1513, 10.1001/archderm.142.11.1513.
16. Sitaru C., Chiriac M.T., Mihai S., Büning J., Gebert A., Ishiko A., et al. Induction of complement-fixing autoantibodies against type VII collagen results in subepidermal blistering in mice. J Immunol 2006, 177(5):3461-3468.
17. Mihai S., Chiriac M.T., Takahashi K., Thurman J.M., Holers V.M., Zillikens D., et al. The alternative pathway of complement activation is critical for blister induction in experimental epidermolysis bullosa acquisita. J Immunol 2007, 178(10):6514-6521.
18. Chiriac M.T., Roesler J., Sindrilaru A., Scharffetter-Kochanek K., Zillikens D., Sitaru C. NADPH oxidase is required for neutrophil-dependent autoantibody-induced tissue damage. J Pathol 2007, 212(1):56-65. URL. http://dx.doi.org/10.1002/path.2157, 10.1002/path.2157.
19. Liu Z., Sui W., Zhao M., Li Z., Li N., Thresher R., et al. Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model. J Autoimmun 2008, 31(4):331-338. URL. http://dx.doi.org/10.1016/j.jaut.2008.08.009, 10.1016/j.jaut.2008.08.009.
20. Iwata H., Kamio N., Aoyama Y., Yamamoto Y., Hirako Y., Owaribe K., et al. IgG from patients with bullous pemphigoid depletes cultured keratinocytes of the 180-kDa bullous pemphigoid antigen (type XVII collagen) and weakens cell attachment. J Invest Dermatol 2009, 129(4):919-926. URL. http://dx.doi.org/10.1038/jid.2008.305, 10.1038/jid.2008.305.
21. Nimmerjahn F., Ravetch J.V. Divergent immunoglobulin G subclass activity through selective Fc receptor binding. Science 2005, 310(5753):1510-1512. URL. http://dx.doi.org/10.1126/science.1118948, 10.1126/science.1118948.
22. Bruhns P., Iannascoli B., England P., Mancardi D.A., Fernandez N., Jorieux S., et al. Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses. Blood 2009, 113(16):3716-3725. URL. http://dx.doi.org/10.1182/blood-2008-09-179754, 10.1182/blood-2008-09-179754.
23. Brüggemann M., Williams G.T., Bindon C.I., Clark M.R., Walker M.R., Jefferis R., et al. Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies. J Exp Med 1987, 166(5):1351-1361.
24. Tao M.H., Smith R.I., Morrison S.L. Structural features of human immunoglobulin G that determine isotype-specific differences in complement activation. J Exp Med 1993, 178(2):661-667.
25. Platts-Mills T., Vaughan J., Squillace S., Woodfolk J., Sporik R. Sensitisation, asthma, and a modified Th2 response in children exposed to cat allergen: a population-based cross-sectional study. Lancet 2001, 357(9258):752-756. URL. http://dx.doi.org/10.1016/S0140-6736(00)04168-4, 10.1016/S0140-6736(00)04168-4.
26. Hamano H., Kawa S., Horiuchi A., Unno H., Furuya N., Akamatsu T., et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001, 344(10):732-738.
27. Mubarak H.S.E., Ibrahim S.A., Vos H.W., Mukhtar M.M., Mustafa O.A., Wild T.F., et al. Measles virus protein-specific IgM, IgA, and IgG subclass responses during the acute and convalescent phase of infection. J Med Virol 2004, 72(2):290-298. URL. http://dx.doi.org/10.1002/jmv.10553, 10.1002/jmv.10553.
28. van der Neut Kolfschoten M., Schuurman J., Losen M., Bleeker W.K., Martínez-Martínez P., Vermeulen E., et al. Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange. Science 2007, 317(5844):1554-1557. URL. http://dx.doi.org/10.1126/science.1144603, 10.1126/science.1144603.
29. Valim Y.M.L., Lachmann P.J. The effect of antibody isotype and antigenic epitope density on the complement-fixing activity of immune complexes: a systematic study using chimaeric anti-NIP antibodies with human Fc regions. Clin Exp Immunol 1991, 84(1):1-8.
30. Vidarsson G., van Der Pol W.L., van Den Elsen J.M., Vilé H., Jansen M., Duijs J., et al. Activity of human IgG and IgA subclasses in immune defense against Neisseria meningitidis serogroup B. J Immunol 2001, 166(10):6250-6256.
31. Mooney E., Gammon W.R. Heavy and light chain isotypes of immunoglobulin in epidermolysis bullosa acquisita. J Invest Dermatol 1990, 95(3):317-319.
32. Bernard P., Prost C., Aucouturier P., Durepaire N., Denis F., Bonnetblanc J.M. The subclass distribution of IgG autoantibodies in cicatricial pemphigoid and epidermolysis bullosa acquisita. J Invest Dermatol 1991, 97(2):259-263.
33. Cho H.J., Lee I.J., Kim S.C. Complement-fixing abilities and IgG subclasses of autoantibodies in epidermolysis bullosa acquisita. Yonsei Med J 1998, 39(4):339-344.
34. Gandhi K., Chen M., Aasi S., Lapiere J.C., Woodley D.T., Chan L.S. Autoantibodies to type VII collagen have heterogeneous subclass and light chain compositions and their complement-activating capacities do not correlate with the inflammatory clinical phenotype. J Clin Immunol 2000, 20(6):416-423.
35. Culton D.A., Qian Y., Li N., Rubenstein D., Aoki V., Filhio G.H., et al. Advances in pemphigus and its endemic pemphigus foliaceus (Fogo Selvagem) phenotype: a paradigm of human autoimmunity. J Autoimmun 2008, 31(4):311-324. URL. http://dx.doi.org/10.1016/j.jaut.2008.08.003, 10.1016/j.jaut.2008.08.003.
36. Qaqish B.F., Prisayanh P., Qian Y., Andraca E., Li N., Aoki V., et al. Development of an IgG4-based predictor of endemic pemphigus foliaceus (Fogo Selvagem). J Invest Dermatol 2009, 129(1):110-118.
37. Mihai S., Chiriac M.T., Herrero-González J.E., Goodall M., Jefferis R., Savage C.O.S., et al. IgG4 autoantibodies induce dermal-epidermal separation. J Cell Mol Med 2007, 11(5):1117-1128. URL. http://dx.doi.org/10.1111/j.1582-4934.2007.00081.x, 10.1111/j.1582-4934.2007.00081.x.
38. Krebber A., Bornhauser S., Burmester J., Honegger A., Willuda J., Bosshard H.R., et al. Reliable cloning of functional antibody variable domains from hybridomas and spleen cell repertoires employing a reengineered phage display system. J Immunol Methods 1997, 201(1):35-55.
39. Boel E., Verlaan S., Poppelier M.J., Westerdaal N.A., Strijp J.A.V., Logtenberg T. Functional human monoclonal antibodies of all isotypes constructed from phage display library-derived single-chain Fv antibody fragments. J Immunol Methods 2000, 239(1-2):153-166.
40. Zillikens D., Kawahara Y., Ishiko A., Shimizu H., Mayer J., Rank C.V., et al. A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone. J Invest Dermatol 1996, 106(6):1333-1338.
41. Katz S.I., Hertz K.C., Yaoita H. Herpes gestationis. Immunopathology and characterization of the HG factor. J Clin Invest 1976, 57(6):1434-1441. URL. http://dx.doi.org/10.1172/JCI108413, 10.1172/JCI108413.
42. R Development Core Team R: a language and environment for statistical computing 2008, R Foundation for Statistical Computing, Vienna, Austria, URL. http://www.r-project.org.
43. Payne A.S., Ishii K., Kacir S., Lin C., Li H., Hanakawa Y., et al. Genetic and functional characterization of human pemphigus vulgaris monoclonal autoantibodies isolated by phage display. J Clin Invest 2005, 115(4):888-899. URL. http://dx.doi.org/10.1172/JCI24185, 10.1172/JCI24185.
44. Ishii K., Lin C., Siegel D.L., Stanley J.R. Isolation of pathogenic monoclonal anti-desmoglein 1 human antibodies by phage display of pemphigus foliaceus autoantibodies. J Invest Dermatol 2008, 128(4):939-948. URL. http://dx.doi.org/10.1038/sj.jid.5701132, 10.1038/sj.jid.5701132.
45. Sesarman A., Mihai S., Chiriac M.T., Olaru F., Sitaru A.G., Thurman J.M., et al. Binding of avian IgY to type VII collagen does not activate complement and leucocytes and fails to induce subepidermal blistering in mice. Br J Dermatol 2008, 158(3):463-471. URL. http://dx.doi.org/10.1111/j.1365-2133.2007.08388.x, 10.1111/j.1365-2133.2007.08388.x.
46. Saeland E., Vidarsson G., Leusen J.H.W., Garderen E.V., Nahm M.H., Vile-Weekhout H., et al. Central role of complement in passive protection by human IgG1 and IgG2 anti-pneumococcal antibodies in mice. J Immunol 2003, 170(12):6158-6164.
47. Zenzo GD, Calabresi V, Olasz EB, Zambruno G, Yancey KB. Sequential intramolecular epitope spreading of humoral responses to human BPAG2 in a transgenic model. J Invest Dermatol. , URL http://dx.doi.org/10.1038/jid.2009.309.
48. Sitaru C., Schmidt E., Petermann S., Munteanu L.S., Bröcker E.-B., Zillikens D. Autoantibodies to bullous pemphigoid antigen 180 induce dermal-epidermal separation in cryosections of human skin. J Invest Dermatol 2002, 118(4):664-671.
49. Clynes R., Maizes J.S., Guinamard R., Ono M., Takai T., Ravetch J.V. Modulation of immune complex-induced inflammation in vivo by the coordinate expression of activation and inhibitory Fc receptors. J Exp Med 1999, 189(1):179-185.
50. Pricop L., Redecha P., Teillaud J.L., Frey J., Fridman W.H., Sautès-Fridman C., et al. Differential modulation of stimulatory and inhibitory Fc gamma receptors on human monocytes by Th1 and Th2 cytokines. J Immunol 2001, 166(1):531-537.
51. Belostocki K., Pricop L., Redecha P.B., Aydin A., Leff L., Harrison M.J., et al. Infliximab treatment shifts the balance between stimulatory and inhibitory Fcgamma receptor type II isoforms on neutrophils in patients with rheumatoid arthritis. Arthritis Rheum 2008, 58(2):384-388. URL. http://dx.doi.org/10.1002/art.23200, 10.1002/art.23200.
52. Ravetch J.V., Perussia B. Alternative membrane forms of Fc gamma RIII(CD16) on human natural killer cells and neutrophils. Cell type-specific expression of two genes that differ in single nucleotide substitutions. J Exp Med 1989, 170(2):481-497.
53. Salmon J.E., Millard S., Schachter L.A., Arnett F.C., Ginzler E.M., Gourley M.F., et al. Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans. J Clin Invest 1996, 97(5):1348-1354. URL. http://dx.doi.org/10.1172/JCI118552, 10.1172/JCI118552.
54. Fossati G., Bucknall R.C., Edwards S.W. Fcgamma receptors in autoimmune diseases. Eur J Clin Invest 2001, 31(9):821-831.
55. Holland M., Hewins P., Goodall M., Adu D., Jefferis R., Savage C.O.S. Anti-neutrophil cytoplasm antibody IgG subclasses in Wegener's granulomatosis: a possible pathogenic role for the IgG4 subclass. Clin Exp Immunol 2004, 138(1):183-192. URL. http://dx.doi.org/10.1111/j.1365-2249.2004.02566.x, 10.1111/j.1365-2249.2004.02566.x.
56. Aitman T.J., Dong R., Vyse T.J., Norsworthy P.J., Johnson M.D., Smith J., et al. Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans. Nature 2006, 439(7078):851-855. URL. http://dx.doi.org/10.1038/nature04489, 10.1038/nature04489.
57. Breunis W.B., van Mirre E., Bruin M., Geissler J., de Boer M., Peters M., et al. Copy number variation of the activating FCGR2C gene predisposes to idiopathic thrombocytopenic purpura. Blood 2008, 111(3):1029-1038. URL. http://dx.doi.org/10.1182/blood-2007-03-079913, 10.1182/blood-2007-03-079913.
58. Weisenseel P., Martin S., Partscht K., Messer G., Prinz J.C. Relevance of the low-affinity type of the Fcgamma-receptor IIIa-polymorphism in bullous pemphigoid [short communication]. Arch Dermatol Res 2007, 299(3):163-164. URL. http://dx.doi.org/10.1007/s00403-007-0755-8, 10.1007/s00403-007-0755-8.
59. Zillikens D., Derfler K., Eming R., Fierlbeck G., Goebeler M., Hertl M., et al. Recommendations for the use of immunoapheresis in the treatment of autoimmune bullous diseases. J Dtsch Dermatol Ges 2007, 5(10):881-887. URL. http://dx.doi.org/10.1111/j.1610-0387.2007.06342.x, 10.1111/j.1610-0387.2007.06342.x.
60. Nouri-Aria K.T., Wachholz P.A., Francis J.N., Jacobson M.R., Walker S.M., Wilcock L.K., et al. Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity. J Immunol 2004, 172(5):3252-3259.